These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22180043)

  • 1. Mammalian cells as biopharmaceutical production hosts in the age of omics.
    Dietmair S; Nielsen LK; Timmins NE
    Biotechnol J; 2012 Jan; 7(1):75-89. PubMed ID: 22180043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering mammalian cells in bioprocessing - current achievements and future perspectives.
    Lim Y; Wong NS; Lee YY; Ku SC; Wong DC; Yap MG
    Biotechnol Appl Biochem; 2010 Apr; 55(4):175-89. PubMed ID: 20392202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of flow-cytometric analysis to optimize cell banking strategies for production of biopharmaceuticals from mammalian cells.
    Fieder J; Wagner N; Grammatikos S; Hoffmann H; Kaufmann H; Otto RT
    J Biotechnol; 2005 Oct; 120(1):111-20. PubMed ID: 16043250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of exocytic SNAREs on the production of recombinant proteins in mammalian cells.
    Peng RW; Abellan E; Fussenegger M
    Biotechnol Bioeng; 2011 Mar; 108(3):611-20. PubMed ID: 21246508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and engineering of microbial cells based on proteomics and its conjunction with other omics studies.
    Han MJ; Lee JW; Lee SY
    Proteomics; 2011 Feb; 11(4):721-43. PubMed ID: 21229587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of multi-omics techniques for bioprocess design and optimization in chinese hamster ovary cells.
    Farrell A; McLoughlin N; Milne JJ; Marison IW; Bones J
    J Proteome Res; 2014 Jul; 13(7):3144-59. PubMed ID: 24915626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glyco-engineering in plants to produce human-like N-glycan structures.
    Castilho A; Steinkellner H
    Biotechnol J; 2012 Sep; 7(9):1088-98. PubMed ID: 22890723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian cell protein expression for biopharmaceutical production.
    Zhu J
    Biotechnol Adv; 2012; 30(5):1158-70. PubMed ID: 21968146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analyses in the interaction of Neisseria meningitidis with mammalian host cells.
    Joseph B; Frosch M; Schoen C; Schubert-Unkmeir A
    Methods Mol Biol; 2012; 799():267-93. PubMed ID: 21993652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systems biotechnology of mammalian cell factories.
    O'Callaghan PM; James DC
    Brief Funct Genomic Proteomic; 2008 Mar; 7(2):95-110. PubMed ID: 18326543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
    Sivakumar G
    Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic proteomics in mammalian cells: capabilities and challenges.
    Milo R
    Mol Biosyst; 2007 Aug; 3(8):542-6. PubMed ID: 17639129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHO gene expression profiling in biopharmaceutical process analysis and design.
    Schaub J; Clemens C; Schorn P; Hildebrandt T; Rust W; Mennerich D; Kaufmann H; Schulz TW
    Biotechnol Bioeng; 2010 Feb; 105(2):431-8. PubMed ID: 19777598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTS technologies in biopharmaceutical discovery.
    Wu G; Doberstein SK
    Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A detailed understanding of the enhanced hypothermic productivity of interferon-gamma by Chinese-hamster ovary cells.
    Fox SR; Tan HK; Tan MC; Wong SC; Yap MG; Wang DI
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):255-64. PubMed ID: 15504103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond silencing--engineering applications of RNA interference and antisense technology for altering cellular phenotype.
    Hebert CG; Valdes JJ; Bentley WE
    Curr Opin Biotechnol; 2008 Oct; 19(5):500-5. PubMed ID: 18760358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics and fluxomics approaches.
    Cascante M; Marin S
    Essays Biochem; 2008; 45():67-81. PubMed ID: 18793124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing mammalian cell culture engineering using genome-scale technologies.
    Griffin TJ; Seth G; Xie H; Bandhakavi S; Hu WS
    Trends Biotechnol; 2007 Sep; 25(9):401-8. PubMed ID: 17681628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation of serum free media with HT is not sufficient to restore growth properties of DHFR-/- cells in fed-batch processes - Implications for designing novel CHO-based expression platforms.
    Florin L; Lipske C; Becker E; Kaufmann H
    J Biotechnol; 2011 Apr; 152(4):189-93. PubMed ID: 21345355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New role for tobacco--production of biopharmaceuticals].
    Budzianowski J
    Przegl Lek; 2009; 66(10):894-7. PubMed ID: 20301965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.